David Braun(@BraunMDPhD) 's Twitter Profileg
David Braun

@BraunMDPhD

Oncologist, physician-scientist @YaleCancer @YaleMed | cancer immunotherapy, genomics, kidney cancer | tweets ≠ medical advice. ASCO FCOI:https://t.co/IsIqZTpy9c

ID:990313941149548544

linkhttps://www.thebraunlab.org/ calendar_today28-04-2018 19:36:57

1,1K Tweets

2,9K Followers

1,1K Following

Müschen Lab(@MuschenLab) 's Twitter Profile Photo

Proud mentor alert: Etienne Leveille gave a spectacular overview of our work at the first international meeting on 'Oncogene hyperactivation' as a new paradigm to treat cancer. Harnessing oncogene hyperactivation to induce negative selection in B-cell malignancies.

Proud mentor alert: Etienne Leveille gave a spectacular overview of our work at the first international meeting on 'Oncogene hyperactivation' as a new paradigm to treat cancer. Harnessing oncogene hyperactivation to induce negative selection in B-cell malignancies.
account_circle
OncLive.com(@OncLive) 's Twitter Profile Photo

.David Braun, of Yale Cancer Center, highlights recent data focused on nivolumab plus cabozantinib in patients with non–clear cell renal cell carcinoma. onclive.com/view/nivolumab…

account_circle
Nazli Dizman(@NazliDizman) 's Twitter Profile Photo

⏰Don't miss the abstract submission deadline, folks!
Excellent opportunity to learn latest advancements in research, meet the community and build new collaborations.
📅 Mon 5/6
Link 👉tinyurl.com/3xthrwk4
Hope to see you all in Boston!…

account_circle
Neeraj Agarwal, MD, FASCO(@neerajaiims) 's Twitter Profile Photo

Just in Cancer Cell 👉Validation of the molecular clusters of the IMmotion151 trial in the JAVELIN Renal 101 dataset : Excellent commentary highlighting these biomarkers by our fellow Chadi Hage Chehade 👇tinyurl.com/48px5rw8 GU Cancer Research Program @HuntsmanCancer OncoAlert UroToday.com KidneyCAN

Just in @Cancer_Cell 👉Validation of the molecular clusters of the IMmotion151 trial in the JAVELIN Renal 101 dataset #kidneycancer: Excellent commentary highlighting these biomarkers by our fellow @chadihc98 👇tinyurl.com/48px5rw8 @Huntsman_GU @OncoAlert @urotoday @kidneycan
account_circle
David Braun(@BraunMDPhD) 's Twitter Profile Photo

Phenomenal 'debate' session highlighting the challenges in IMDC favorable risk, and strategies for choosing a comparator arm for future trials. Tremendously thoughtful discussions from Cris Ignacio Duran Martin Voss and Dr. Bernard Escudier Kidney Cancer

account_circle
KCCure(@kcCURE) 's Twitter Profile Photo

A mother fighting to stay alive for her young children. A young woman sharing her experience with debilitating side effects. Real stories of people living with . Thank you Kidney Cancer for hosting this panel at . Thank you to these brave pts for sharing.

A mother fighting to stay alive for her young children. A young woman sharing her experience with debilitating side effects. Real stories of people living with #kidneycancer. Thank you @KidneyCancer for hosting this panel at #IKCSEU24. Thank you to these brave pts for sharing.
account_circle
David Braun(@BraunMDPhD) 's Twitter Profile Photo

An outstanding and comprehensive overview of chromophobe RCC biology by Martin Voss . Please see the recent review for more discussion on the biology of this tumor type in Cancer Cell cell.com/cancer-cell/ab…
Kidney Cancer

An outstanding and comprehensive overview of chromophobe RCC biology by @MVossMD #IKCSEU24. Please see the recent review for more discussion on the biology of this tumor type in @Cancer_Cell cell.com/cancer-cell/ab… @KidneyCancer
account_circle
David Braun(@BraunMDPhD) 's Twitter Profile Photo

Dr. Ferran Algaba Arrea providing an excellent overview of the increasingly complex classification, including correlations between morphological features and molecular alterations Kidney Cancer

Dr. Ferran Algaba Arrea providing an excellent overview of the increasingly complex classification, including correlations between morphological features and molecular alterations #IKCSEU24 @KidneyCancer
account_circle
David Braun(@BraunMDPhD) 's Twitter Profile Photo

Really important talk from Turajlic Lab @ The Crick about genomic -> transcriptomic -> proteomic tools for classifications, including challenges and strategies for effective molecular classification and biomarker development Kidney Cancer

Really important talk from @TurajlicLab about genomic -> transcriptomic -> proteomic tools for classifications, including challenges and strategies for effective molecular classification and biomarker development #IKCSEU24 @KidneyCancer
account_circle
David Braun(@BraunMDPhD) 's Twitter Profile Photo

An excellent, balanced discussion of adjuvant therapy in RCC from Brian Rini, MD Tom Powles Uromigos . An area of consensus - we need better ways to risk stratification risk of recurrence, including biomarkers Kidney Cancer

An excellent, balanced discussion of adjuvant therapy in RCC from @brian_rini @tompowles1 @Uromigos . An area of consensus - we need better ways to risk stratification risk of recurrence, including biomarkers #IKCSEU24 @KidneyCancer
account_circle
Eddy Saad(@eddy_saad) 's Twitter Profile Photo

Excited to share our work The Oncologist co-led by Georges Gebrael and mentored by Toni Choueiri, MD Daniel Heng

While smoking cessation is crucial 🚭, smoking status does not independently affect outcomes in pts w/ treated w/ 1L ICI

OncoAlert UroToday.com
tinyurl.com/mv44nycci

Excited to share our work @OncJournal co-led by @ggebraelmd and mentored by @DrChoueiri @DrDanielHeng While smoking cessation is crucial 🚭, smoking status does not independently affect outcomes in pts w/ #mRCC treated w/ 1L ICI @OncoAlert @urotoday tinyurl.com/mv44nycci
account_circle